Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Seattle Genetics Announces Agreement with Immunomedics for Sacituzumab Govitecan, a Promising Late-S

americanpharmaceuticalreviewFebruary 13, 2017

Tag: Sacituzumab Govitecan , ADC

PharmaSources Customer Service